Galectin Therapeutics Inc. (GALT) Jumps 5.43% on January 14

Equities Staff |

Galectin Therapeutics Inc. (GALT) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 5.43% to $1.35, representing a gain of $0.0695 per share. Some 56,818 shares traded hands on 271 trades, compared with an average daily volume of 131,247 shares out of a total float of 23.93 million. The stock opened at $1.26 and traded with an intraday range of $1.39 to $1.25.

After today's gains, Galectin Therapeutics Inc. reached a market cap of $32.29 million. Galectin Therapeutics Inc. has had a trading range between $4.40 and $1.24 over the last year, and it had a 50-day SMA of $2.00 and a 200-day SMA of $2.52.

Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Galectin Therapeutics Inc. is based out of Norcross, GA and has some 7 employees. Its CEO is Peter G. Traber.

For a complete fundamental analysis analysis of Galectin Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for GALT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Margaux Resources Ltd.

Margaux Resources Ltd is a Calgary based resource company. The Company is focused on its Jersey Emeral Tungsten-Zinc property located in the southeast portion of British Columbia.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.